ChAd155-RSV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ChAd155-RSV, covering 2018-08-20 to 2018-08-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults [Phase 1]